Gene · 1828
Papers3,287
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,287
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modeling reproductive and pregnancy-associated tissues using organ-on-chip platforms: challenges, limitations, and the high throughput data frontier. | Front Bioeng Biotechnol | 2025 | 40236940 | PubTator, text mining | PubMed |
| Clinical Responses and Transcriptomic Analysis of Spesolimab in a Girl With Severe Dermatitis, Multiple Allergies and Metabolic Wasting Syndrome. | Exp Dermatol | 2025 | 40207438 | PubTator, text mining | PubMed |
| Interleukin (IL)-34 promotes the inflammatory role of IL-1β-producing myeloid cells in pemphigus lesions. | Br J Dermatol | 2025 | 40203120 | PubTator, text mining | PubMed |
| Epitomic profiling and functional characteristics of pemphigus vulgaris autoantibody binding to keratinocyte M3 muscarinic acetylcholine receptor. | J Biol Chem | 2025 | 40120680 | PubTator, text mining | PubMed |
| New insights into pyroptosis in pemphigus: from cellular structure to therapeutic targeting. | An Bras Dermatol | 2025 | 40102153 | PubTator, text mining | PubMed |
| Comparison of clinical efficacy and cost-effectiveness of rituximab infusion and intravenous dexamethasone pulse therapy in pemphigus vulgaris: an open prospective randomized controlled pilot study. | Clin Exp Dermatol | 2025 | 40100754 | PubTator, text mining | PubMed |
| Decreased PAX6 and DSG1 Protein Expression in Corneal Epithelium of Patients with Epithelial Basal Membrane Dystrophy, Salzmann Nodular Degeneration, and Pterygium. | J Clin Med | 2025 | 40094891 | PubTator, text mining | PubMed |
| Comparative analysis of demographics and clinical outcomes in patients with pemphigus vulgaris and foliaceus with high versus normal anti-desmoglein levels post-complete remission. | Arch Dermatol Res | 2025 | 40085247 | PubTator, text mining | PubMed |
| Antidesmoglein 1 and 3 serum IgG and positivity by direct immunofluorescence microscopy is associated with relapse in pemphigus in a prospective bicontinental study. | JAAD Int | 2025 | 40084347 | PubTator, text mining | PubMed |
| Can the count and percentage of immature granulocytes be used to detect disease activity in patients with pemphigus?: A preliminary study. | Medicine (Baltimore) | 2025 | 40068041 | PubTator, text mining | PubMed |
| Clinical Features, Diagnosis and Treatment of Different Types of Paediatric Pemphigus. | Acta Derm Venereol | 2025 | 40059466 | PubTator, text mining | PubMed |
| A novel hierarchical control strategy for enhancing stability of a DC microgrid feeding a constant power load. | Sci Rep | 2025 | 40016478 | PubTator, text mining | PubMed |
| Developing a dynamic combined power quality index for assessing the performance of a nuclear facility. | Sci Rep | 2025 | 40000648 | PubTator, text mining | PubMed |
| The Identification of FN1 as an Early Diagnostic Marker for Recurrent Abortion by Single-Exosome Profiling. | Int J Gen Med | 2025 | 39963517 | PubTator, text mining | PubMed |
| Coexistence of T-Cell Lymphoblastic Lymphoma and Ichthyosis Vulgaris: A Case Report. | Case Rep Oncol Med | 2025 | 39949400 | PubTator, text mining | PubMed |
| In vitro and ex vivo models of the oral mucosa as platforms for the validation of novel drug delivery systems. | J Tissue Eng | 2025 | 39944725 | PubTator, text mining | PubMed |
| Diagnostic methods and strategies for autoimmune bullous diseases. | Expert Rev Clin Immunol | 2025 | 39930606 | PubTator, text mining | PubMed |
| Ephrin-Eph signaling: an important regulator of epithelial integrity and barrier function. | Tissue Barriers | 2025 | 39921660 | PubTator, text mining | PubMed |
| Optimizing Pemphigus Management With Rituximab and Short-Term Relapse Predictors. | JAMA Dermatol | 2025 | 39908046 | PubTator, text mining | PubMed |
| An observational study to determine the role of indirect immunofluorescence and ELISA for desmogleins in the diagnosis and monitoring of autoimmune bullous disorders. | Med J Armed Forces India | 2025 | 39872186 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1828/papers?page=7